STTK STTK
Company Profile ↓Company Overview
STTK (STTK) is a publicly traded company listed on with a market capitalization of $466.37M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Recent Developments
- Dec 2025 Revenue of $1.00M (-82.5% YoY); net profit $-48.81M.
- Trailing 12 Months Year-on-year growth — revenue -82.5%.
- 5-Year Trend Long-term compounding — revenue CAGR -31.7%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -31.74% |
| 1 Year: | -82.52% |
Stock Price Performance
| 1 Year: | +906.83% |
| 6 Months: | +88.97% |
| 3 Months: | +12.69% |
| 1 Month: | +1.52% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)55.72 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Revenue declined at -31.7% CAGR over 5 years.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | 1.78M | 2.98M | 3.18M | 2.44M | 2.27M | -4.23M | 1.90M | 0 | 50.00K | 212.00K | 57.00K | 200.00K | 686.00K | 1.11M | 1.61M | 3.00M | 0 | 0 | 1.00M | 0 | 0 |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 14.39M | 13.03M | 11.72M | 13.37M | 15.54M |
| Operating Income | - | - | -7.53M | -6.76M | -6.32M | -11.84M | -12.42M | -24.51M | -17.58M | -24.17M | -27.66M | -25.23M | -21.66M | -22.75M | -28.60M | -20.04M | -22.96M | -17.92M | -14.39M | -13.03M | -10.72M | -13.37M | -15.54M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -13.45M | -12.10M | -9.80M | -12.46M | -14.65M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -13.70M | -12.46M | -10.06M | -12.59M | -14.77M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income | -3.45M | -5.88M | -7.28M | -6.55M | -6.21M | -11.83M | -11.81M | -23.60M | -17.41M | -24.53M | -27.37M | -24.64M | -20.72M | -21.35M | -27.54M | -18.50M | -21.55M | -16.68M | -13.70M | -12.46M | -10.06M | -12.59M | -14.77M |
| Diluted EPS | - | - | - | - | -0.81 | -1.54 | -0.28 | -0.56 | -0.41 | -0.58 | -0.65 | -0.58 | -0.49 | -0.50 | -0.65 | -0.37 | -0.42 | -0.33 | -0.27 | -0.24 | -0.14 | -0.12 | -0.13 |
| R&D Expense | - | - | 7.95M | 8.14M | 7.75M | 11.80M | 10.34M | 14.88M | 15.14M | 19.19M | 22.96M | 18.86M | 16.67M | 18.20M | 24.21M | 16.26M | 19.24M | 16.31M | 9.92M | 8.68M | 7.62M | - | 10.95M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 9.89M | 9.93M | 30.02M | 652.00K | 1.66M | 5.72M | 1.00M |
| Cost of Revenue | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - |
| Operating Expenses | - | - | - | 103.98M | 93.61M | 86.29M | 52.51M |
| Operating Income | -25.07M | -36.93M | -45.27M | -103.33M | -91.96M | -80.57M | -51.51M |
| EBITDA | - | - | - | -100.26M | -87.92M | -76.74M | -47.82M |
| Interest Expense | - | - | - | - | - | - | - |
| Pretax Income | - | - | - | -101.94M | -87.30M | -75.41M | -48.81M |
| Tax Provision | - | - | - | - | - | - | - |
| Net Income | -23.98M | -36.60M | -44.97M | -101.94M | -87.30M | -75.41M | -48.81M |
| Diluted EPS | - | -2.36 | -1.07 | -2.41 | -2.05 | -1.49 | -0.70 |
| R&D Expense | 29.22M | 37.48M | 56.56M | 82.90M | 74.31M | 67.21M | 35.27M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | - | 44.97M | 348.99M | - | 205.32M | 159.56M | 91.05M | 91.03M |
| Current Assets | - | - | - | - | 184.58M | 143.22M | 79.22M | 82.47M |
| Cash & Equivalents | - | 7.01M | 157.90M | - | 47.38M | 125.63M | 57.39M | 54.19M |
| Inventory | - | - | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - | - | - |
| Total Liabilities | - | 30.45M | 39.13M | - | 29.17M | 14.86M | 11.42M | 8.64M |
| Current Liabilities | - | 19.98M | 16.83M | - | 24.96M | 11.45M | 8.92M | 7.05M |
| Long Term Debt | - | - | - | - | - | - | - | - |
| Total Debt | - | - | - | - | 4.90M | 4.20M | 3.41M | 2.42M |
| Total Equity | -11.08M | -34.55M | 309.86M | - | 176.16M | 144.71M | 79.63M | 82.39M |
| Shares Outstanding | - | - | - | - | 42.39M | 47.26M | 47.71M | 63.28M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -20.98M | -33.66M | - | -94.50M | -81.23M | -60.52M | -39.88M |
| Investing Cash Flow | -3.59M | -146.32M | - | 49.44M | 110.86M | -8.51M | -7.89M |
| Financing Cash Flow | -64.00K | 330.87M | - | 171.00K | 48.62M | 787.00K | 44.57M |
| Capital Expenditure | -470.00K | -727.00K | - | -11.61M | -407.00K | -59.00K | -71.00K |
| Free Cash Flow | -21.45M | -34.39M | - | -106.11M | -81.64M | -60.57M | -39.95M |
| Net Change in Cash | - | - | - | -44.89M | 78.25M | -68.24M | -3.19M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - |
| Operating Margin % | -253.5% | -371.8% | -150.8% | -15,848.0% | -5,549.6% | -1,408.3% | -5,150.8% |
| Net Margin % | -242.6% | -368.5% | -149.8% | -15,635.7% | -5,268.4% | -1,318.1% | -4,880.9% |
| ROE % | 69.4% | -11.8% | - | -57.9% | -60.3% | -94.7% | -59.2% |
| ROCE % | -100.3% | -11.1% | - | -57.3% | -62.1% | -98.1% | -61.3% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for STTK
Why Shattuck Labs Stock Flew Nearly 5% Higher on Friday - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxPYmRSV25qNGdYZEI4SG05a3hOajhrMEo1M0Y4TTF0QUJpRlozNHlRdG1nQVFJU1NaTzBSS2xnRXpiZktBbWNTVW1YWlhnUE9pTndlZmZTOU9TR2ZrcF9lanFpSVNvZ1JMcExzRUFNbXZJTDVJRnpINldLOVZPZm9tRVpydmE0X1plNVlMNn…
Biotech Shattuck Labs sets terms for $75M stock, warrant sale - Stock Titan
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxOc3R2VmI3V1c4RzdadlRYaEl4SjRKeWtuM2l5cWtQRGU2ZkUwekFwN0pUOHRyTFk4cV9EbTNXMFpUaVFkcFI0ZWdidUU2YTN4NXFUcFFQQm0zWUoybDQxT0xvVHF3UlpoRTBtXzhwdERwVnVySFZFc1hpaU5JdFN5X0szNzZpcmdTTkFoc0…
Shattuck Labs, Inc. Revenue Breakdown – NASDAQ:STTK - TradingView
<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTFByZHJaSlJUaDd2VERxbWlUU0FrelhoekRoeVl0dHlXUUJSMHZmeEFrZi1vdXgzel8xS0lCN2pmeUkwV0dwV3QtTk5rZVAzUUx1NUNzWTdSRHlVVFZMUlVuTHhMSVlfbnVhTmViV0thcHpPYTNxT0pn?oc=5" target="_blank">Shattuc…
STTK|Shattuck Labs Inc|Price:7.070|Chg%:-0.120 - TradingKey
<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE02YkhOMWYxV01tVkMzYVFNS2dKbmd1RWUwb3Mza1duSWltbHd4SmtsZFpwNXdrM2FJYWJUY1BRVVJlRXh1dTIxaGR6VWZKQ2RNdTRPVUJscjRCV1BmZUVnOGZVS1lKeTJ0T2xta01R?oc=5" target="_blank">STTK|Shattuck Labs …
This Shattuck Labs Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday - webull.com
<a href="https://news.google.com/rss/articles/CBMiWEFVX3lxTFBNUnJjY2RkNVBYdWhOb1docmpZVXVFMzJFbEV4NTdsQlZkT3lYRVdGYlotZHlpaUdJdTBQTXdLek1LZmVfRmZyOHNEWXNqSm9scjBSdEJnSDY?oc=5" target="_blank">This Shattuck Labs Analyst Begins Coverage On A …
STTK Initiated Coverage by JP Morgan -- Rating Set at Overweight - GuruFocus
<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxQd2IzMjk5ZjlQZkpHb1ltTGJ4ekpKbEFRNTBGbG1weElVZzZlcHVtUGx0bzdxZTRxRkRzdEIycEprajdEZ3kwcHhvRHpjamhLQUpfVjQ2NGlFMDRqV0Nld19aaFk1WDlYZGpxQ3lsY3JjZEFTamw2S2dUakN2a1hyR1pCNE1YQklDWjItR0…
STTK — Frequently Asked Questions
What is the current share price of STTK?
As of 2026-08-05 17:25 PDT, STTK trades at $7.37 on NASDAQ/NYSE. Its 52-week range is $0.73 to $7.92.
What is the market capitalisation of STTK?
STTK has a market capitalisation of $466.37M on NASDAQ/NYSE.
What is the P/E ratio of STTK?
STTK trades at a trailing price-to-earnings (P/E) ratio of -10.53. Its price-to-book (P/B) ratio is 5.66.
What is the return on equity (ROE) of STTK?
STTK has a return on equity (ROE) of -59.24%. Its return on capital employed (ROCE) is -61.34%.
Is STTK a good stock to buy?
This page provides a data-driven analysis of STTK, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.